Genotypic resistance of archived and circulating viral strains in the blood of treated HIV-infected individuals.

Ombretta Turriziani, Mauro Bucci, Armando Stano, Carolina Scagnolari, Francesca Bellomi, Caterina Fimiani, Ivano Mezzaroma, Gabriella D'Ettorre, Andrea Brogi, Vincenzo Vullo, Guido Antonelli

Journal: Journal of acquired immune deficiency syndromes (1999) 2007;44(5):518-24

PMID: 17224845

Abstract

The aim of this study was to evaluate patterns of antiretroviral resistance of HIV-1 in peripheral blood mononuclear cells (PBMCs) and in the plasma of patients whose therapeutic regimen is failing. Plasma and PBMC samples were collected from 95 HIV-infected patients undergoing long-term treatment. Genotyping of the reverse transcriptase (RT) and protease genes of HIV-1 was undertaken using the fluorescent dideoxy-terminator method. Comparison of the amino acid sequence of the RT and protease genes in cell-associated variants of HIV-1 with that of the plasma revealed that 62 of the 95 patients' samples tested exhibited different genotypic resistance patterns (discordant samples [DSs]). In 27% of samples, the patterns of resistance detected were concordant in both compartments. In 51% of DSs, the greatest number of mutations was found in plasma; however, in 37% of DSs, greater numbers of mutations were found in PBMC DNA. The HIV mutation patterns detected in plasma do not necessarily reflect those found in the cell-associated compartment. The observation that the cellular compartment may contain an archive of the resistance variant makes this reservoir an interesting substrate for analysis of the "resistance potential" in a given patient.

Address: Virology Section, Department of Experimental Medicine, Policlinico Umberto I, University La Sapienza, Viale di Porta Tiburtina 28, 00185 Rome, Italy. [email protected]
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.